POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA

被引：8
|
作者：
Tamura, N. [1 ]
Kuwana, M. [2 ]
Atsumi, T. [3 ]
Takei, S. [4 ]
Harigai, M. [5 ]
Fujii, T. [6 ]
Matsuno, H. [7 ]
Mimori, T. [8 ]
Momohara, S. [9 ]
Yamamoto, K. [10 ]
Nomura, K. [11 ]
Endo, Y. [11 ]
Sugiyama, N. [11 ]
Hirose, T. [11 ]
Morishima, Y. [11 ]
Yoshii, N. [11 ]
Takagi, M. [12 ]
机构：
[1] Juntendo Univ, Tokyo, Japan
[2] Nippon Med Sch, Tokyo, Japan
[3] Hokkaido Univ, Sapporo, Hokkaido, Japan
[4] Kagoshima Univ, Kagoshima, Japan
[5] Tokyo Womens Med Univ, Tokyo, Japan
[6] Wakayama Med Univ, Wakayama, Japan
[7] Matsuno Clin Rheumat Dis, Toyama, Japan
[8] Kyoto Univ, Kyoto, Japan
[9] Hakkeikai Inc Med Inst, Shizuoka, Japan
[10] Univ Tokyo, Tokyo, Japan
[11] Pfizer Japan Inc, Tokyo, Japan
[12] Yamagata Univ, Fac Med, Yamagata, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.3521
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0495
引用
收藏
页码：1408 / 1408
页数：1
相关论文
共 50 条
  • [1] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
    Mimori, Tsuneyo
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Kuwana, Masataka
    Takei, Syuji
    Tamura, Naoto
    Fujii, Takao
    Matsuno, Hiroaki
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Kokubo, Takeshi
    Endo, Yutaka
    Sugiyama, Naonobu
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Mimori, T.
    Harigai, M.
    Atsumi, T.
    Kuwana, M.
    Takei, S.
    Tamura, N.
    Fuji, T.
    Matsuno, H.
    Momohara, S.
    Yamamoto, K.
    Kokubo, T.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1200 - 1201
  • [3] Infection Events in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim All-Case Post-Marketing Surveillance
    Tamura, Naoto
    Kuwana, Masataka
    Atsumi, Tatsuya
    Takei, Syuji
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Mimori, Tsuneyo
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Nomura, Kazuto
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Sugiyama, Naonobu
    Yoshii, Noritoshi
    Takagi, Michiaki
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Malignancy in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim Analysis of All-Case Post-Marketing Surveillance
    Tamura, Naoto
    Kuwana, Masataka
    Atsumi, Tatsuya
    Takei, Syuji
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Mimori, Tsuneyo
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Nomura, Kazuto
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Sugiyama, Naonobu
    Yoshii, Noritoshi
    Takagi, Michiaki
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Tanigawa, Miki
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    Mimori, Tsuneyo
    Takagi, Michiaki
    [J]. MODERN RHEUMATOLOGY, 2024, 34 (02) : 272 - 286
  • [6] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Burmester, Gerd R.
    Coates, Laura C.
    Cohen, Stanley B.
    Tanaka, Yoshiya
    Vranic, Ivana
    Nagy, Edward
    Lazariciu, Irina
    Chen, All-shine
    Kwok, Kenneth
    Fallon, Lara
    Kinch, Cassandra
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (05) : 1255 - 1276
  • [7] POST-MARKETING SAFETY SURVEILLANCE OF TOFACITINIB OVER 9 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
    Burmester, G. R.
    Coates, L.
    Cohen, S. B.
    Tanaka, Y.
    Vranic, I.
    Nagy, E.
    Chen, A. S.
    Lazariciu, I.
    Kwok, K.
    Fallon, L.
    Kinch, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 347 - 348
  • [8] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Gerd R. Burmester
    Laura C. Coates
    Stanley B. Cohen
    Yoshiya Tanaka
    Ivana Vranic
    Edward Nagy
    Irina Lazariciu
    All-shine Chen
    Kenneth Kwok
    Lara Fallon
    Cassandra Kinch
    [J]. Rheumatology and Therapy, 2023, 10 : 1255 - 1276
  • [9] Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study
    Ju, Ji Hyeon
    Sung, Yoon-Kyoung
    Jo, Joo-young
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Lee, Eun Bong
    [J]. MODERN RHEUMATOLOGY, 2023, 33 (06) : 1087 - 1096
  • [10] Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance
    Kameda, Hideto
    Tasaka, Sadatomo
    Takahashi, Toshiya
    Suzuki, Katsuhisa
    Soeda, Naoki
    Tanaka, Yoshiya
    [J]. MODERN RHEUMATOLOGY, 2024, 34 (03) : 444 - 452
12345